QCM
XENE icon

Quantinno Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History

Quantinno Capital Management’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.84M Buy
63,652
+8,208
+15% +$456K ﹤0.01% 1454
2026
Q1 		$3.22M Buy
55,444
+30,816
+125% +$1.42M 0.01% 1348
2025
Q4 		$1.1M Buy
24,628
+11,257
+84% +$473K ﹤0.01% 1724
2025
Q3 		$537K Buy
+13,371
New +$471K ﹤0.01% 1956

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Quantinno Capital Management's XENE Position: Q2 2026 in Review

Quantinno Capital Management increased its Xenon Pharmaceuticals (XENE) stake by 15% in Q2 2026, buying an estimated $456K and bringing the position to 63,652 shares worth $3.84M. The position accounts for ﹤0.01% of the portfolio, ranked #1454.

Quantinno Capital Management first reported a position in XENE in Q3 2025 and has held it in 4 quarters since. 315 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • Quantinno Capital Management held 63,652 shares of Xenon Pharmaceuticals worth $3.84M as of Q2 2026.
  • Quantinno Capital Management bought 8,208 Xenon Pharmaceuticals shares in Q2 2026, an estimated $456K.
  • Xenon Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1454 holding.
  • Quantinno Capital Management first reported a position in Xenon Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 315 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.